Healthcare News

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways...

European Patent Office granted Vaxart a new patent, extending intellectual property protection for Vaxart’s Norovirus vaccine program through at least 2036 across key European marketsKEY HIGHLIGHTS:•...

RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent...

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Disclosure of transactions in own shares Paris, France (August 26, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026,...

Déclaration de transactions sur actions propres Paris, France (26 août 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 28 avril 2026, EssilorLuxottica déclare que...

        PRESS RELEASE                 Paris, 26th August 2026 Provisional annual results at the end of June 2026 Revenue growth and disciplined efficiency drive stronger operational...

            COMMUNIQUE DE PRESSE                 Paris, 26 août 2026 Résultats annuels provisoires à fin juin 2026 Croissance du chiffre d’affaires et discipline financière contribuent à...

JAMA Dermatology publication includes results from VALOR skin-specific secondary endpoints, with rapid and durable improvements seen for brepocitinib 30 mg compared to placebo across multiple...